BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Panlilio LV, Stull SW, Bertz JW, Burgess-Hull AJ, Lanza ST, Curtis BL, Phillips KA, Epstein DH, Preston KL. Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use. Psychopharmacology (Berl) 2021;238:1513-29. [PMID: 33558983 DOI: 10.1007/s00213-021-05782-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Clingan SE, Cousins SJ, Lin C, Nguyen TE, Hser YI, Mooney LJ. Perceptions of COVID-19 risk during the pandemic: perspectives from people seeking medication for opioid use disorder. Ann Med 2023;55:480-9. [PMID: 36692029 DOI: 10.1080/07853890.2023.2169342] [Reference Citation Analysis]
2 Mantsch JR. Corticotropin releasing factor and drug seeking in substance use disorders: Preclinical evidence and translational limitations. Addict Neurosci 2022;4:100038. [PMID: 36531188 DOI: 10.1016/j.addicn.2022.100038] [Reference Citation Analysis]
3 Mcreynolds JR, Wolf CP, Starck DM, Schaps R, Krause LA, Hillard CJ, Mantsch JR. Role of mesolimbic cannabinoid receptor 1 in stress-driven increases in cocaine self-administration in male rats.. [DOI: 10.1101/2022.10.28.514315] [Reference Citation Analysis]
4 Votaw VR, Tuchman FR, Piccirillo ML, Schwebel FJ, Witkiewitz K. Examining Associations Between Negative Affect and Substance Use in Treatment-Seeking Samples: a Review of Studies Using Intensive Longitudinal Methods. Curr Addict Rep. [DOI: 10.1007/s40429-022-00441-8] [Reference Citation Analysis]
5 Ellis JD, Mun CJ, Epstein DH, Phillips KA, Finan PH, Preston KL. Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder. Neuropsychopharmacology 2022;47:1836-43. [PMID: 35668168 DOI: 10.1038/s41386-022-01352-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Peart DR, Andrade AK, Logan CN, Knackstedt LA, Murray JE. Regulation of Cocaine-related Behaviors by Estrogen and Progesterone. Neuroscience & Biobehavioral Reviews 2022. [DOI: 10.1016/j.neubiorev.2022.104584] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
7 Marsch LA, Chen CH, Adams SR, Asyyed A, Does MB, Hassanpour S, Hichborn E, Jackson-Morris M, Jacobson NC, Jones HK, Kotz D, Lambert-Harris CA, Li Z, McLeman B, Mishra V, Stanger C, Subramaniam G, Wu W, Campbell CI. The Feasibility and Utility of Harnessing Digital Health to Understand Clinical Trajectories in Medication Treatment for Opioid Use Disorder: D-TECT Study Design and Methodological Considerations. Front Psychiatry 2022;13:871916. [PMID: 35573377 DOI: 10.3389/fpsyt.2022.871916] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Price JL, Bates ME, Pawlak AP, Uhouse SG, Todaro SM, Morgano J, Buckman JF. Use and perceived usefulness of a just-in-time resonance breathing intervention adjunct for substance use disorder: Contextual and physiological predictors. Front Psychiatry 2022;13:945751. [PMID: 36159943 DOI: 10.3389/fpsyt.2022.945751] [Reference Citation Analysis]
9 Burgess-Hull AJ, Smith KE, Schriefer D, Panlilio LV, Epstein DH, Preston KL. Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: A growth-mixture-model approach to classifying patients. Drug Alcohol Depend 2021;226:108884. [PMID: 34229153 DOI: 10.1016/j.drugalcdep.2021.108884] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]